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Introduction
Trauma remains an important medical problem. A se-
ries of scores and algorithms were elaborated to estimate 
the severity and to predict the treatment results for injured 
patients, but, actually, there are no any universal scores 
[1]. Moreover, existing scores applied in different medical 
systems or different populations with their specific demo-
graphic structure showed different ability to predict the out-
comes [2, 3]. This, in turn, makes researchers be active in ef-
ficient variables/biomarkers identification that will increase 
the potential models’ predictive power. 
The potential source for biomarkers in trauma patients 
is the components of proteases/antiproteases system. These 
elements are some active immune response participants 
in trauma and especially in severe trauma, activated by 
Systemic Inflammatory Response Syndrome (SIRS) devel-
opment with proteases release by neutrophils in both, in-
jured and non-injured tissues [4, 5]. Thus, the proteases and 
their antagonists, antiproteases, could be used as predictors 
in survival predictive models. At the same time, the relation-
ships between proteases/antiproteases system elements are, 
evidently, complex and this is why it is more rational to use 
some integrative indicators for analyses. This allows char-
acterizing pathophysiological process/processes instead of 
individual proteases or antiproteases effect/effectsPrincipal 
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Abstract
Background: Assessing the traumatic injuries severity, as well as estimating the severe trauma patient’s prognosis are the key moments in their management. 
Predictive models for severe trauma outcome need improvement. 
Material and methods: In the clinical study (65 severe trauma patients), proteases, antiproteases and treatment outcome (survival/non-survival) were 
considered. There were used two statistical instruments – dimension reduction analysis (principal component analysis) to prepare the data for modeling 
and modeling itself through multivariate logistic regression. 
Results: Principal component analysis evidenced 12 “latent” factors grouped in four models. The survival predictive model had the following characteristics: 
calibration χ²=1.547, df=7, р=.981; determination – 0.759; discrimination, sensitivity – 90.7%, specificity – 81.8 %, area under RОС curve – 0.95 (95%CI 
0.912, 1.000). The model enrolled four “latent” factors (three destructive and one protective), male gender and ARDS development. 
Conclusions:  In our research, the survival predictive model for severe trauma patients on base of proteases/antiproteases system components after 
dimension reduction procedure was elaborated. The model showed good characteristics and needs validation to be implemented in daily clinical practice.
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component analysis represents a statistical instrument for 
dimension reduction. Analyzing dataset, this method ex-
tracts the “latent” factors, which are the numerical expres-
sion (quantification) of pathophysiological/fundamental 
factors/processes involved in traumas evolution and out-
come, including the appearance of indirect lesions. Each 
extracted factor is estimated by linear regression technique, 
having at least two predictors and is used for modeling in-
stead of initial variables [6].
The aim of this research was to elaborate a survival pre-
dictive model for severe trauma patients on base of prote-
ases/antiproteases system components after dimension re-
duction procedure.
Material and methods
Ethical committee of Nicolae Testemitanu State Uni-
versity of Medicine and Pharmacy (Chisinau, the Republic 
of Moldova) approved the study design (Protocol 33/46 of 
16.12.2016).
In a clinical prospective analytical study, 65 severe trau-
ma patients admitted within first 24 hours after trauma in 
Intensive Care Unit of Emergency Medicine Institute (ICU 
EMI), Chisinau, The Republic of Moldova, were enrolled. 
Plasma samples (venous blood) were collected at 3, 6, 12 and 
24 hours after traumatic impact, the potential model being 
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applicable at 24 hours after trauma. For every blood sam-
ple, there were estimated 10 proteases/antiproteases system 
parameters – two antiproteases (α2-macroglobulin (α2M), 
α1-antitrypsin (α1AT)) and eight proteases (Cathepsin D ac-
tivity (CDA), Cathepsin H activity (CHA), Cathepsin L ac-
tivity (CLA), Cathepsin G activity (CGA), Elastase activity 
(EA), Trypsin activity (TA), Adenosinedesaminase activity 
(ASDS) and Adenilatdesaminase activity (ALDS). In addi-
tion, gender (binary variable), aging (continuous variable), 
Acute Respiratory Distress Syndrome (ARDS) develop-
ment (binary variable) were considered for modeling. The 
outcome (dependent variable) was trauma patient survival 
(survived or non-survived). Criteria for severe trauma was 
NISS more than 15 points [7], ARDS diagnosis being deter-
mined considering Berlin definition [8].
To achieve the aim of study, two statistical instruments – 
dimension reduction (principal component analysis (PCA, 
varimax rotation) and multivariate logistic regression were 
used. Through dimension reduction analysis were ex-
tracted as named “latent” factors, maximal three for every 
PCA model. Also, taking into account the relatively small 
patients sample Kaiser-Meyer-Olkin (KMO) (measures of 
how suited your data is for factor analysis) and Bartlett (if 
the number of extracted factors was appropriate) tests were 
applied. If KMO was more than .5 and Bartlet test was sig-
nificant (Bonferroni correction for multiple comparisons) 
the model was considered for further analysis. In addition, 
the PCA models were optimized by variable elimination 
if correlation coefficient was less than .6 or if a parameter 
was associated with two extracted factors and difference be-
tween the absolute correlation values was less than .3.
Extracted “latent” factors, being estimated quantita-
tively (continuous variable), together with other potential 
predictors mentioned above were considered for model-
ing through multivariate logistic regression (backward 
conditional method). To estimate the model’s predictive 
potential, were considered the following characteristics: de-
termination (Nagelkerke R Square), calibration (Hosmer–
Lemeshow test and classification plots) and discrimination 
(specificity, sensibility, area under ROC curve and sensibili-
ty/specificity optimization by cut-off changing). In addition, 
were appreciated model’s stability (resampling by bootstrap-
ping) and multicollinearity analysis.
Results
According to PCA results (tab. 1), there were evidenced 
4 models, corresponding to 4 blood samples, collected at 3, 
6, 12 and 24 hours after trauma. Each model had 3 ”latent” 
(extracted) factors. Every factor, in turn, enrolled between 2 
and 5 proteases/antiproteases system components. In addi-
tion, taking into account the parameters that estimated the 
factors, it was possible to identify, at least presumably, the 
potential factors roles, divided into potentially destructive 
or potentially protective.
Within multiple regression analysis for outcome predic-
tion, the data collected at 24 hours after the trauma were 
considered (ARDS diagnosis, Age, Gender and “latent” fac-
tors estimated before). The null hypothesis – the model’s co-
variates are not able to predict the survival probability better 
than a model with constant only. The alternative hypothesis 
– at least one covariate is able to predict the survival prob-
ability better than a model with constant only. The null hy-
pothesis was rejected by Omnibus Test of Model Coefficients 
(χ2 = 51.569, df=6, p<.001, significance level (α) being .05.
Determination coefficient (Nagelkerke R Square), 
showed the value .759 (75.9%) – more than 75% from sur-
vival probability dispersion was explained by the elaborated 
model’s covariates. 
The calibration (Hosmer–Lemeshow test) had closed to 
ideal value of χ2 = 1.547, df=7, p=.981, being nonsignificant, 
and confirmed the results fidelity.
The discrimination properties (cut-off was increased up 
to .55 for accuracy increasing) had the optimal values for 
specificity 81.8% (18 out of 22), sensibility 90.7% (39 out of 
Table 1
The principal component analysis output (varimax rotation)
Sample timing, hours after 
trauma
Extracted factors Components Potential effect
3 hours
1st Factor α2M3, CHA3, TA3 Protective
2nd factor ASDS3, ALDS3 Destructive
3rd factor EA3, CDA3 Destructive
6 hours
1st Factor ASDS6, ALDS6, α2M6 (negative correlation) Destructive
2nd factor CHA6, TA6, α2M6 Protective
3rd factor EA6, CGA6, CDA6 Destructive
12 hours
1st Factor 
α1AT12 (negative correlation), TA12, ASDS12, EA12 (negative 
correlation), α2M12
Protective
2nd factor ALDS12, CDA12, CLA12 Destructive
3rd factor CHA12, CGA12 Destructive
24 hours
1st Factor EA24, α1AT24 Destructive
2nd factor TA24, α2M24, CGA24 Protective
3rd factor ASDS24, ALDS24 Destructive
α2-macroglobulin (α2M), α1-antitrypsin (α1AT), Cathepsin D activity (CDA), Cathepsin H activity (CHA), Cathepsin L activity (CLA), Cathepsin G 
activity (CGA), Elastase activity (EA), Trypsin activity (TA), Adenosinedesaminase activity (ASDS) and Adenilatdesaminase activity (ALDS).
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The final model included the constant (B=7.816), ARDS 
diagnosis (B=-4.731), male gender (-.333), the values of 
factor 2model 2 (B=4.038), factor 3model 1 (-2.752), factor 2model 3 
(-2.623) and factor 2model 4 (-2.623) (tab. 2). The variable Age 
and other extracted factors did not show significance, the 
proposed model being represented as follows:
p =  (formula 1), where
р – 3ability to survive 
b = 7.816 + 4.038 x factor 2model2 - 2.752 x factor 3model1 
- 2.623 x factor 2model3 - 1.504 x factor 2model4 - 3.333 x male - 
4.731 x ARDSe (exponent) – constant equal to 2.71828
The resampling procedure by bootstrapping (999 sam-
ples) showed the significance of potential predictors evi-
denced in elaborated models, without signs inversion, 95% 
CI for coefficients being relatively wide (tab. 2b).
Discussion
The alternative approach, used in this research, especial-
ly “preparing” the data for modeling by PCA allowed taking 
into account proteases/antiproteases components in com-
plex, as physiopathological elements instead of individual 
role of separated elements. Finally, four significant extracted 
factors took part from elaborated predictive model (tab. 1 
and 2).
Table 2
Coefficients for elaborated model equation (a) and bootstrapping for variables in the equation (b)
a. Final model coefficients
B S.E. Wald df Sig. Exp(B)
95% С.I. for EXР(B)
Lower Upper
ARDS diagnosis -4.731 1.739 7.397 1 .007 .009 .000 .267
factor 3model 1 -2.752 .883 9.723 1 .002 .064 .011 .360
factor 2model 2 4.038 1.292 9.767 1 .002 56.693 4.506 713.222
factor 2model 3 -2.623 .950 7.617 1 .006 .073 .011 .468
Male gender -3.333 1.513 4.851 1 .028 .036 .002 .693
factor 2model 4 -1.504 .751 4.011 1 .045 .222 .051 .968
Constant 7.816 2.555 9.362 1 .002 2480.270
b. Bootstrap for Variables in the Equation
B Bias S.E. Sig.
95% Confidence Interval for B
Lower Upper
ARDS diagnosis -4.731 -89.957 715.811 .002 -615.579 -2.512
factor 3model 1 -2.752 -45.593 305.169 .003 -389.184 -1.728
factor 2model 2 4.038 86.037 528.509 .002 2.488 671.286
factor 2model 3 -3.333 -62.414 372.735 .006 -562.397 -.793
Male gender -2.623 -53.494 413.554 .001 -381.894 -1.756
factor 2model 4 -1.504 -22.276 133.442 .004 -143.446 -.403
Constant 7.816 140.631 1045.749 .001 5.189 1136.440
Fig. 1.  Area under ROC curve for survival predictive model 
based on data collected within first 24 hours after trauma
 Constant – equation constant’s value, B – B coefficients, S.E. – standard errors, Wald – Wald statistics, df – de-
grees of freedom, Sig. – significance threshold, Exp (B) – odds ratio values, 95% C.I. for EXP(B) – 95% confidence 
interval for odds ratio.
43) and overall percentage (87.7%), all these parameters be-
ing higher than target value of 80%. Area under RОС curve 
for proposed model was estimated at level of .956 (95%CI 
0.912, 1) and represented significance in relation to the val-
ue of .5 (р<0.001) (fig. 1).
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The third extracted factor (PCA model at 3 hours) was 
in positive association with two proteases – AE3 and ACD3, 
the factor was estimated as destructive one (tab 1). In ac-
cordance with literature the elastase represents the key sub-
stance in both, direct and indirect lung lesions [9], having 
multiple destructive effects as degradation the elastin fibers, 
ciliar apparatus lesions, apoptosis amplification etc. [10]. 
Moreover, the elastase represents multiple рrоinflаmmаtоry 
effects [11]. Cathepsin D, in turn, was demonstrated to 
have ability for enzyme, hormones, antigen and neuro-
peptide processing, having a function to activate Caspase 
8, an important element in apoptosis cascade. In addition, 
Cathepsin D showed complement activation and increasing 
for trauma patients [12].
The second extracted factor (PCA model at 6 hours) was, 
probably, protective because of positive association with 
trypsin and α2-macroglobulin. The last one represents the 
antiprotease substance, that is able to inactivate almost all 
proteases [13]. Trypsin, unexpectedly, in different research 
showed a series of positive effects as anti-inflammatory, an-
tiedematic, antioxidant, first two effects demonstrated for 
trauma patients [14, 15]. The Cathepsin H positive associa-
tion could be explained by incomplete determination coef-
ficient abilities in linear regression equation for extracted 
factors in PCA.
The PCA model at 12 hours evidenced 3 factors, second 
one being significant for final predictive model. This factor 
was estimated as destructive because of positive association 
with three proteases – AAMP, ACD and ACL.  Cathepsin 
L, in accordance with literature data, represented a proteo-
lytic activity for almost all proteins, including enzymes and 
receptors [16]. It is associated with Cathepsin D, controlled 
aрорtоsis and neovascularization, enrolled in immune re-
sponse [17]. 
The second extracted factor from the fourth PCA model 
was explained by trypsin, α2-macroglobulin and cathepsin G 
values, all components having positive association. Taking 
into account this, especially first two, the “latent” factor was 
interpreted as protective one. However, the equation for “la-
tent” factor quantitative estimation included cathepsin G, 
which represents a series of potential negative effects. It is 
able to activate coagulation cascade, immune response, to 
destroy the vascular matrices and to generate edema [18-
21]. This, in turn, probably, determined the destructive na-
ture of this parameter, trypsin, α2-macroglobulin being just 
associated with severity of potential lesions without direct 
implication.
Regarding the final predictive model, the main result of 
this study, it is important to mention good characteristics de-
spite of relatively small sample size (one of the limitations). 
At the same time, resampling showed the reproductibility 
of the experiment. The model had relatively high determi-
nant coefficient, the value being close to 80%. Calibration 
and discrimination showed good model fit and good sensi-
bility/specificity abilities. The most important covariate was 
factor 3model 1 (AE and ACD as predictors). It determined 
23% of dependent variable dispersion. Speculating, AE and 
AED inhibition within first 3 hours after trauma could be 
a perspective direction for further researches. On the sec-
ond place was factor 2model 2 (17.1%), followed by ARDS di-
agnosis (12.7%), male gender (10.3%), factor 2model 3 (7.3%) 
and factor 2 model 4 (5.5%). These data suggest idea about the 
antiprotease treatment optimization in dependence on the 
admission timing, that, was not taken into consideration 
before – possible reason for antiproteases treatment failure 
[22, 23].
In accordance with elaborated model’s results, ARDS, 
factor 3model 1, factor 2model 3, factor 2model 4 and male gender were 
the parameters that decrease survival probability (ОR=.009, 
95%СI .000, .267; OR=.064 95%СI .011, .360; OR=.073, 
95%CI .011, .468; OR=.222, 95%CI .051, .968 and OR=.036, 
CI95% .002, .693, respectively). Factor 2model 2, had a protec-
Fig. 2.  Classification plot for survival predictive model in severe trauma based on data collected within first 24 hours after trauma
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tive effect, OR being 56.693 (СI 95% 4.506, 713.222) (Table 
2a). Resampling (bootstrapping, 999 samples) showed wide 
confidence intervals for model’s covariates with significance 
and no changing signs in front of parameters. In addition,it 
is important to mention no multicollinearity between pre-
dictors included in the final model.
Conclusions
In our research, the survival predictive model for severe 
trauma patients on base of proteases/antiproteases system 
components after dimension reduction procedure was elab-
orated. The model showed good characteristics and needs 
validation to be implemented in daily clinical practice.
Dimension reduction analysis with ”latent” factor ex-
traction has a perspective in research with numerous po-
tential biochemical parameters, taking into account their 
complex interactions, estimated factors, probably, being 
quantitatively estimated for different pathophysiological 
mechanisms.
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